[Influenza].
Identifieur interne : 000524 ( Main/Exploration ); précédent : 000523; suivant : 000525[Influenza].
Auteurs : Christian Chidiac [France]Source :
- La Revue du praticien [ 0035-2640 ] ; 2008.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Amantadine (administration et posologie), Amantadine (usage thérapeutique), Antibactériens (administration et posologie), Antibactériens (usage thérapeutique), Antiviraux (administration et posologie), Antiviraux (usage thérapeutique), Complications infectieuses de la grossesse (MeSH), Diagnostic différentiel (MeSH), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Facteurs de risque (MeSH), Facteurs temps (MeSH), Facteurs âges (MeSH), Femelle (MeSH), France (épidémiologie), Grippe humaine (complications), Grippe humaine (diagnostic), Grippe humaine (prévention et contrôle), Grippe humaine (thérapie), Grippe humaine (traitement médicamenteux), Grippe humaine (transmission), Grippe humaine (épidémiologie), Grossesse (MeSH), Humains (MeSH), Mâle (MeSH), Nourrisson (MeSH), Oséltamivir (administration et posologie), Oséltamivir (usage thérapeutique), Résultat thérapeutique (MeSH), Saisons (MeSH), Sujet âgé (MeSH), Vaccins antigrippaux (administration et posologie), Zanamivir (administration et posologie), Zanamivir (usage thérapeutique), Études de suivi (MeSH).
- MESH :
- administration et posologie : Amantadine, Antibactériens, Antiviraux, Oséltamivir, Vaccins antigrippaux, Zanamivir.
- diagnostic : Grippe humaine.
- prévention et contrôle : Grippe humaine.
- thérapie : Grippe humaine.
- traitement médicamenteux : Grippe humaine.
- usage thérapeutique : Amantadine, Antibactériens, Antiviraux, Grippe humaine, Oséltamivir, Zanamivir.
- épidémiologie : France, Grippe humaine.
- Adolescent, Adulte, Complications infectieuses de la grossesse, Diagnostic différentiel, Enfant, Enfant d'âge préscolaire, Facteurs de risque, Facteurs temps, Facteurs âges, Femelle, Grossesse, Humains, Mâle, Nourrisson, Résultat thérapeutique, Saisons, Sujet âgé, Études de suivi.
- Wicri :
- geographic : France.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Age Factors (MeSH), Aged (MeSH), Amantadine (administration & dosage), Amantadine (therapeutic use), Anti-Bacterial Agents (administration & dosage), Anti-Bacterial Agents (therapeutic use), Antiviral Agents (administration & dosage), Antiviral Agents (therapeutic use), Child (MeSH), Child, Preschool (MeSH), Diagnosis, Differential (MeSH), Female (MeSH), Follow-Up Studies (MeSH), France (epidemiology), Humans (MeSH), Infant (MeSH), Influenza Vaccines (administration & dosage), Influenza, Human (complications), Influenza, Human (diagnosis), Influenza, Human (drug therapy), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (therapy), Influenza, Human (transmission), Male (MeSH), Oseltamivir (administration & dosage), Oseltamivir (therapeutic use), Pregnancy (MeSH), Pregnancy Complications, Infectious (MeSH), Risk Factors (MeSH), Seasons (MeSH), Time Factors (MeSH), Treatment Outcome (MeSH), Zanamivir (administration & dosage), Zanamivir (therapeutic use).
- MESH :
- chemical , administration & dosage : Amantadine, Anti-Bacterial Agents, Antiviral Agents, Influenza Vaccines, Oseltamivir, Zanamivir.
- chemical , therapeutic use : Amantadine, Anti-Bacterial Agents, Antiviral Agents, Oseltamivir, Zanamivir.
- geographic , epidemiology : France.
- complications : Influenza, Human.
- diagnosis : Influenza, Human.
- drug therapy : Influenza, Human.
- epidemiology : Influenza, Human.
- prevention & control : Influenza, Human.
- therapy : Influenza, Human.
- transmission : Influenza, Human.
- Adolescent, Adult, Age Factors, Aged, Child, Child, Preschool, Diagnosis, Differential, Female, Follow-Up Studies, Humans, Infant, Male, Pregnancy, Pregnancy Complications, Infectious, Risk Factors, Seasons, Time Factors, Treatment Outcome.
PubMed: 18506987
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Influenza].</title>
<author><name sortKey="Chidiac, Christian" sort="Chidiac, Christian" uniqKey="Chidiac C" first="Christian" last="Chidiac">Christian Chidiac</name>
<affiliation wicri:level="1"><nlm:affiliation>Maladies infectieuses et tropicales, hôpital de la Croix-Rousse, 69317 Lyon Cedex 04. christian.chidiac@chu-lyon.fr</nlm:affiliation>
<country wicri:rule="url">France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:18506987</idno>
<idno type="pmid">18506987</idno>
<idno type="wicri:Area/Main/Corpus">000537</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000537</idno>
<idno type="wicri:Area/Main/Curation">000537</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000537</idno>
<idno type="wicri:Area/Main/Exploration">000537</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Influenza].</title>
<author><name sortKey="Chidiac, Christian" sort="Chidiac, Christian" uniqKey="Chidiac C" first="Christian" last="Chidiac">Christian Chidiac</name>
<affiliation wicri:level="1"><nlm:affiliation>Maladies infectieuses et tropicales, hôpital de la Croix-Rousse, 69317 Lyon Cedex 04. christian.chidiac@chu-lyon.fr</nlm:affiliation>
<country wicri:rule="url">France</country>
</affiliation>
</author>
</analytic>
<series><title level="j">La Revue du praticien</title>
<idno type="ISSN">0035-2640</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Age Factors (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Amantadine (administration & dosage)</term>
<term>Amantadine (therapeutic use)</term>
<term>Anti-Bacterial Agents (administration & dosage)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Antiviral Agents (administration & dosage)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Diagnosis, Differential (MeSH)</term>
<term>Female (MeSH)</term>
<term>Follow-Up Studies (MeSH)</term>
<term>France (epidemiology)</term>
<term>Humans (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza, Human (complications)</term>
<term>Influenza, Human (diagnosis)</term>
<term>Influenza, Human (drug therapy)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (therapy)</term>
<term>Influenza, Human (transmission)</term>
<term>Male (MeSH)</term>
<term>Oseltamivir (administration & dosage)</term>
<term>Oseltamivir (therapeutic use)</term>
<term>Pregnancy (MeSH)</term>
<term>Pregnancy Complications, Infectious (MeSH)</term>
<term>Risk Factors (MeSH)</term>
<term>Seasons (MeSH)</term>
<term>Time Factors (MeSH)</term>
<term>Treatment Outcome (MeSH)</term>
<term>Zanamivir (administration & dosage)</term>
<term>Zanamivir (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Amantadine (administration et posologie)</term>
<term>Amantadine (usage thérapeutique)</term>
<term>Antibactériens (administration et posologie)</term>
<term>Antibactériens (usage thérapeutique)</term>
<term>Antiviraux (administration et posologie)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Complications infectieuses de la grossesse (MeSH)</term>
<term>Diagnostic différentiel (MeSH)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Facteurs de risque (MeSH)</term>
<term>Facteurs temps (MeSH)</term>
<term>Facteurs âges (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>France (épidémiologie)</term>
<term>Grippe humaine (complications)</term>
<term>Grippe humaine (diagnostic)</term>
<term>Grippe humaine (prévention et contrôle)</term>
<term>Grippe humaine (thérapie)</term>
<term>Grippe humaine (traitement médicamenteux)</term>
<term>Grippe humaine (transmission)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Grossesse (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Nourrisson (MeSH)</term>
<term>Oséltamivir (administration et posologie)</term>
<term>Oséltamivir (usage thérapeutique)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Saisons (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Zanamivir (administration et posologie)</term>
<term>Zanamivir (usage thérapeutique)</term>
<term>Études de suivi (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Amantadine</term>
<term>Anti-Bacterial Agents</term>
<term>Antiviral Agents</term>
<term>Influenza Vaccines</term>
<term>Oseltamivir</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Amantadine</term>
<term>Anti-Bacterial Agents</term>
<term>Antiviral Agents</term>
<term>Oseltamivir</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>France</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Amantadine</term>
<term>Antibactériens</term>
<term>Antiviraux</term>
<term>Oséltamivir</term>
<term>Vaccins antigrippaux</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Amantadine</term>
<term>Antibactériens</term>
<term>Antiviraux</term>
<term>Grippe humaine</term>
<term>Oséltamivir</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>France</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Diagnosis, Differential</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Infant</term>
<term>Male</term>
<term>Pregnancy</term>
<term>Pregnancy Complications, Infectious</term>
<term>Risk Factors</term>
<term>Seasons</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Complications infectieuses de la grossesse</term>
<term>Diagnostic différentiel</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Facteurs de risque</term>
<term>Facteurs temps</term>
<term>Facteurs âges</term>
<term>Femelle</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Résultat thérapeutique</term>
<term>Saisons</term>
<term>Sujet âgé</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18506987</PMID>
<DateCompleted><Year>2008</Year>
<Month>06</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0035-2640</ISSN>
<JournalIssue CitedMedium="Print"><Volume>58</Volume>
<Issue>4</Issue>
<PubDate><Year>2008</Year>
<Month>Feb</Month>
<Day>29</Day>
</PubDate>
</JournalIssue>
<Title>La Revue du praticien</Title>
<ISOAbbreviation>Rev Prat</ISOAbbreviation>
</Journal>
<ArticleTitle>[Influenza].</ArticleTitle>
<Pagination><MedlinePgn>445-53</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chidiac</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Maladies infectieuses et tropicales, hôpital de la Croix-Rousse, 69317 Lyon Cedex 04. christian.chidiac@chu-lyon.fr</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Grippe.</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Rev Prat</MedlineTA>
<NlmUniqueID>0404334</NlmUniqueID>
<ISSNLinking>0035-2640</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>20O93L6F9H</RegistryNumber>
<NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>BF4C9Z1J53</RegistryNumber>
<NameOfSubstance UI="D000547">Amantadine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>L6O3XI777I</RegistryNumber>
<NameOfSubstance UI="D053243">Zanamivir</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000547" MajorTopicYN="N">Amantadine</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053243" MajorTopicYN="N">Zanamivir</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>8</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year>
<Month>5</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2008</Year>
<Month>6</Month>
<Day>21</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2008</Year>
<Month>5</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">18506987</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
</list>
<tree><country name="France"><noRegion><name sortKey="Chidiac, Christian" sort="Chidiac, Christian" uniqKey="Chidiac C" first="Christian" last="Chidiac">Christian Chidiac</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000524 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000524 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= GrippeFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:18506987 |texte= [Influenza]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:18506987" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a GrippeFranceV1
This area was generated with Dilib version V0.6.35. |